Here come the Zantac Generics
|
Geneva Pharmaceuticals (Broomfield, CO) received final FDA approval for ranitidine in tablet form-the generic equivalent of the best- selling, anti-ulcer medication Zantac-on Friday, Aug. 29, and began shipping the product to customers on Saturday, Aug. 30.
Geneva, one of a handful of companies cleared to market ranitidine, has been manufacturing ranitidine at full capacity over the past month in order to meet demand for the drug. Charles T. Lay, president and chief executive officer of Geneva, said: ``As one of the world's best-selling pharmaceuticals, ranitidine is a tremendous opportunity for Geneva. We are pleased to work with our customers to provide consumers with a generic alternative to Zantac.'' Geneva is part of the Global Generics sector of Novartis, the largest pharmaceutical company worldwide. With a wide-ranging product portfolio, Geneva is one of the largest pharmaceutical manufacturers in the United States. The company is headquartered in Broomfield, Colo., with an additional distribution facility in Knoxville, Tenn. Founded in 1946, Geneva now has more than 1,000 employees. Edited by Nick Basta |